Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
J. P. J. P. Laaban, L. L. Mounier, O. O. Roque d'Orbcastel, J. J. Blacher, D. D. Veale, B. B. Melloni, L. L. Behr, M. M. Grib, L. L. Mallet, M. O. M. O. Debaud, M. M. Merati, F. F. Allouin, J. N. J. N. Prevost, M. P. M. P. Humeau, G. G. Potier (France)
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. P. J. P. Laaban, L. L. Mounier, O. O. Roque d'Orbcastel, J. J. Blacher, D. D. Veale, B. B. Melloni, L. L. Behr, M. M. Grib, L. L. Mallet, M. O. M. O. Debaud, M. M. Merati, F. F. Allouin, J. N. J. N. Prevost, M. P. M. P. Humeau, G. G. Potier (France). Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment. Eur Respir J 2006; 28: Suppl. 50, 4703
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017
Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021
The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007
Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020
Systematic coronary risk evaluation among obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA). Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001